GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a $390 million Series D financing round. New investors including Public Sector Pension Investment Board (PSP Investments) and Canada Pension Plan Investment Board (CPP Investments), as well as two undisclosed investors, joined existing backers including Illumina, Inc. in this round of funding.
Company Information
Company
Grail
Location
1525 O'Brien Drive
Menlo Park, California, United States
About
Grail is a healthcare company focused on the early detection of cancer through its innovative liquid biopsy technology. The company aims to transform cancer diagnosis and treatment by providing tools that detect cancer at its earliest stages. Grail's mission is to help save lives through early cancer detection. The firm blends cutting-edge genetic science with next-generation sequencing.
Fundz sees it the moment Grail raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Menlo ParkBiotechnologyHealth CareGeneticsHealth Diagnosticsresearch